(Circulation. 1995;91:663-670.)
© 1995 American Heart Association, Inc.
Articles |
Dobutamine Echocardiography in Myocardial Hibernation
Optimal Dose and Accuracy in Predicting Recovery of Ventricular Function After Coronary Angioplasty
Presented in part at the 66th Annual Scientific Session of the American Heart Association, November 1993, Atlanta, Ga.
From the Section of Cardiology, Department of Medicine, Baylor College of Medicine, The Methodist Hospital, Echocardiography Laboratory, Houston, Tex.
Correspondence to William A. Zoghbi, MD, The Methodist Hospital, Section of Cardiology, 6535 Fannin, F905, Houston, TX 77030.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Background Myocardial hibernation is a condition of chronic left ventricular dysfunction associated with severe coronary artery disease whereby significant recovery of function occurs after revascularization. Identification of hibernating myocardium has important prognostic and therapeutic implications. The presence of contractile reserve as assessed by dobutamine echocardiography may be promising in the detection of hibernation. We designed a prospective study to evaluate the accuracy and optimal dose of dobutamine echocardiography for predicting recovery of ventricular function after angioplasty in patients with stable coronary artery disease and ventricular dysfunction.
Methods and Results Twenty patients with stable coronary artery
disease and segmental ventricular dysfunction scheduled for coronary
angioplasty underwent dobutamine echocardiography before
revascularization using incremental doses of 2.5, 5, 7.5, 10, 20, 30,
and 40 µg/kg per minute every 3 minutes. Digital images of all eight
stages were displayed simultaneously (two quad screens side by side)
and interpreted using a 16-segment ventricular model and a 6-grade
scoring system. Serial resting echocardiograms before, early (<1
week), and late (
6 weeks) after angioplasty were digitized and
randomized in a quad-screen format for the assessment of recovery of
function. Wall motion score index in the revascularized regions
decreased from 2.86±0.76 before angioplasty to 2.12±1.03 late
after
angioplasty (P<.05). Of 320 ventricular segments, 148 had
abnormal wall motion at baseline and 114 were revascularized. Recovery
of function (2 grades) occurred in 25% of revascularized segments
early and in 33% late after angioplasty. Of the 34 abnormal segments
not revascularized, recovery of function occurred in only 1. During
dobutamine echocardiography, abnormal segments exhibited one of four
responses: biphasic (improvement at low dose and worsening at high
dose) in 28% of segments, sustained improvement (persistent
improvement till peak dose) in 18%, worsening in 15%, and no change
in 39%. A biphasic response had the highest predictive value (72%)
for recovery of function followed by worsening only (35%), while the
lowest was seen with a "no change" or sustained improvement
response (13% and 15%). Combining biphasic and worsening responses
resulted in a sensitivity of 74% and specificity of 73% for
assessment of recovery of individual segments and 90% and 60%,
respectively, for functional recovery of individual patients (n=10). In
segments with a biphasic response, the low dose at which improvement in
wall motion was most prevalent (84%) was 7.5 µg/kg per minute and
increased to 94% when the 5 and 7.5 µg/kg per minute doses were
displayed. The reworsening phase of the biphasic response was usually
seen with doses 20 µg/kg per minute but was also observed as early
as the 7.5 µg/kg per minute dose.
Conclusions The wall motion response during dobutamine echocardiography is useful in the prediction of recovery of ventricular function after revascularization in patients with stable coronary artery disease and ventricular dysfunction. The administration of low as well as high doses of dobutamine is needed for optimal evaluation.
Key Words: echocardiography • coronary disease • myocardium • angioplasty
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
It has been recognized recently that, in patients with coronary artery disease, segmental left ventricular dysfunction may not necessarily represent irreversibly necrosed myocardium.1 2 3 Noncontractile yet viable myocardium may be seen in two syndromes: myocardial stunning and myocardial hibernation. Myocardial stunning results from transient coronary occlusion followed by reperfusion. Ventricular dysfunction persists longer than the duration of occlusion and eventually recovers without intervention.2 Myocardial hibernation, on the other hand, refers to chronic ventricular dysfunction associated with severe coronary artery disease with complete or partial recovery of contractile function occurring after revascularization.3 4
Differentiation of necrosed from viable myocardium has important clinical implications. Identification of hibernating myocardium may allow selection of patients with coronary artery disease whose ventricular function may be improved by revascularization.5 6 7 Inotropic stimulation using dobutamine echocardiography (DE) has been shown to differentiate stunned from infarcted myocardium.8 9 Whether DE can identify hibernating myocardium is unclear at present. Furthermore, the optimal dose of dobutamine needed for the assessment of myocardial viability in this setting is presently unknown. We therefore designed a prospective study to evaluate first, the accuracy of dobutamine echocardiography in the detection of myocardial hibernation in patients with stable coronary artery disease and regional dysfunction undergoing revascularization with percutaneous transluminal coronary angioplasty (PTCA), and second, to evaluate the optimal dose of dobutamine in the detection of myocardial hibernation. Furthermore, the time course of recovery of ventricular function after PTCA was evaluated.
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Patient Enrollment
Patients with coronary artery disease and resting regional left ventricular dysfunction, who were scheduled to undergo PTCA, were screened for enrollment in the study. The investigational protocol was approved by the Institutional Review Boards of Baylor College of Medicine and The Methodist Hospital. Inclusion criteria were age >18 years, presence of significant coronary artery disease defined as a
70% stenosis of at least one major epicardial coronary artery, and
evidence of resting regional left ventricular dysfunction, defined as
any wall motion abnormality present on prior contrast
ventriculography or echocardiography. Patients were already scheduled
to undergo PTCA, and the echocardiographic studies did not influence
the decision to perform or not to perform the angioplasty. The
persistence of wall motion abnormality, initially identified at a mean
of 10±21 days before enrollment, was confirmed with a screening
echocardiogram on the day of the study. Exclusion criteria included patients with unstable angina, recent myocardial infarction (<6 weeks), PTCA of a coronary artery bypass graft, any contraindication to perform DE, or the inability to obtain informed consent.
Echocardiographic Protocol
Each patient underwent a
dobutamine echocardiogram within
24 hours before PTCA. To assess the recovery of ventricular function
and its time course after revascularization, follow-up resting
two-dimensional echocardiograms were performed early (<1 week) and
late (6 to 8 weeks) after angioplasty. The dobu- tamine
echocardiogram was performed using a standard protocol. First, a
resting echocardiogram was performed with the patient lying in left
lateral recumbent position. Echocardiographic imaging was then
performed during the intravenous infusion of dobu- tamine starting
at a dose of 2.5 µg/kg per minute, which was increased every 3
minutes to 5, 7.5, 10, 20, 30, and 40 µg/kg per minute. Images were
obtained from the standard parasternal long-axis and short-axis views
as well as the apical four- and two-chamber views, with particular
attention to optimization of regional function. During the infusion, a
12-lead ECG and blood pressure were monitored every minute. The test
was terminated prematurely if any of the following occurred: 85% of
predicted maximal heart rate, severe angina, systolic blood pressure
<85 or >220 mm Hg, 2 mm ST depression or significant arrhythmia
(6 beats supraventricular tachycardia or 3 beats ventricular
tachycardia).
All studies were performed on a Hewlett-Packard Sonos 1000 or 1500 ultrasound system equipped with a 2.5-MHz transducer and were recorded on half-inch VHS tape. During the study, images were digitized on-line at each of the eight stages of the test (rest and each dobutamine dose) from the four views, using a NovaMicrosonics digitizing system (model 886/AT). The generated cineloops were then stored on floppy disks for later review.
Echocardiographic Image Processing and Analysis
For analysis
of wall motion, the left ventricle was divided
into 16 segments as previously described.10 These
consisted of the anterior, septum, inferior, posterior, and lateral
walls, each subdivided into a basal, mid, and distal portion in
addition to the ventricular apex. Wall motion was assessed visually,
using both endocardial motion and wall thickening,10 and
was semiquantitated using a 6-grade scoring system as follows:
hyperkinesia, 0; normal, 1; mild hypokinesia, 2; hypokinesia, 3;
akinesia, 4; and dyskinesia, 5.
The dobutamine echocardiographic studies were interpreted at random using all eight digital images from each view displayed on two monitors placed side by side to allow simultaneous review of all eight stages of the test. All studies were read by one experienced investigator, blinded to clinical information and results of serial resting echocardiograms. A wall motion score was assigned to each of the 16 segments at every stage of the test.
For the interpretation of changes
in resting ventricular function,
cineloops from each view of the three resting studies (before PTCA and
the two follow-up studies) were generated for each patient. These were
displayed in a quad-screen format in random order and interpreted by
one investigator, blinded to clinical information and timing of the
studies. Recovery of individual segmental dysfunction was defined as an
improvement in resting wall motion score of 2 grades after PTCA. This
was based on a previous analysis of intraobserver variability in
interpretation of regional function from our laboratory in which, using
the above scoring system, reproducibility of grading wall motion of 232
segments in 16 patients was 84% for exact interpretation. Differences
in interpretation by 1 grade of wall motion was seen in 15.5% and in 2
grades in 0.43%. For individual patients, recovery of function was
defined as an improvement in wall motion of 2 grades in at least two
contiguous ventricular segments.
To assess changes in ventricular function in vascular territories, the 16 ventricular segments were grouped into two vascular regions: the left anterior descending coronary artery territory comprising the apical, anterior, and septal segments (n=7), while the other 9 segments formed the combined right and circumflex coronary territory. A wall motion score index (WMSI) was derived for the entire left ventricle and for each vascular territory using the sum of individual scores divided by the respective number of segments.
Coronary Angiography
All angiograms were analyzed by one of
the investigators blinded
to the echocardiographic data. The severity of coronary stenosis was
determined by calipers and expressed as percent of luminal diameter
reduction. The presence or absence of collaterals to the angioplasty
vessel was determined visually. Significant coronary disease was
defined as 70% stenosis of at least one epicardial artery.
Statistical Analysis
Resting regional and global wall motion
score indices and
changes in heart rate, blood pressure, and double product during
dobutamine infusion were compared using ANOVA. If the F value was
significant, a Newman-Keuls multiple comparison test was performed.
Percent vessel stenosis before and after PTCA were compared using the
Student's t test. A 
2 test was used
to study differences in the echocardiographic and angiographic features
of segments with different responses during DE. All values are
expressed as mean±SD. Statistical significance was set at a value of
P<.05.
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Patient Population
A total of 20 patients were enrolled in the study between September 1992 and November 1993. These included 17 men and 3 women with a mean age of 60.3±11.4 years. A history of remote myocardial infarction (mean of 28.3 months before study) was present in 11 patients. A history of stable angina was obtained in 11 patients (55%). All individuals were on antianginal medications including 8 on ß-blockers. None of the patients had unstable angina or recent myocardial infarction. The reason for performing PTCA was stable exertional angina in 9 patients, ischemic response on exercise or pharmacological stress testing in 7, congestive heart failure in 2, coronary restenosis in 1, and preoperative preparation for noncardiac surgery in 1. In the 7 patients referred for PTCA due to detection of ischemia, the decision to perform PTCA was based on a stress test other than DE, performed before enrollment in the study. Twelve patients had single-vessel, 6 had two-vessel, and 2 had multivessel disease. In 5 patients, collaterals to the PTCA vessel were identified on angiography.
Coronary Angioplasty
Coronary angioplasty was successful in
18 of the 20 patients, with
a reduction in mean coronary stenosis from 88.7±8.2% to
21.8±10.6%
(P=.0001). In these patients, a total of 19 vessels were
dilated including 7 right, 6 circumflex, and 6 left anterior descending
coronary arteries. In 2 patients, PTCA was unsuccessful, and
revascularization was achieved with coronary artery bypass surgery. A
saphenous vein graft was placed to the right coronary artery in one
patient, while the other received grafts to both right and left
anterior descending coronary arteries. None of the patients, including
the two in whom PTCA was unsuccessful, had unstable angina or
myocardial infarction after the procedure.
For purposes of analysis, each patient was considered to have two vascular territories, left and combined right and circumflex. Thus, out of 40 vascular territories, 28 were supplied by stenotic vessels, of which 22 were revascularized.
Changes in Resting Ventricular Function After PTCA
Serial
resting echocardiograms were performed a mean of 2.4±2.9
days (early follow-up) and 7±2 weeks (late follow-up) after
angioplasty. A significant improvement in segmental ventricular
function was observed after revascularization (Fig 1
).
Although global WMSI decreased from 2.02±0.92 before angioplasty to
1.83±0.83 at early follow-up, with a further decrease to
1.76±0.81 at
late follow-up, these changes did not reach statistical significance.
However, a significant improvement in regional function was seen in
revascularized territories. In the 22 vascular regions revascularized,
the regional WMSI fell from 2.86±0.76 to 2.34±0.97 early and to
2.12±1.03 late after PTCA (Fig 1). The majority of
improvement in WMSI
(70%) occurred early after revascularization. On the other hand, there
was no significant change in regional WMSI in the six nonrevascularized
regions (Fig 1).
|
Of a total of 320 ventricular segments,
318 were adequately visualized
for wall motion assessment. Abnormal resting wall motion was seen in
148 segments, of which 114 were revascularized (Fig 2).
Significant recovery of resting function (2 grades) was seen in 28
segments (25%) early and in a total of 38 segments (33%) late after
PTCA. In contrast, of the 34 abnormal segments in the distribution of
nonrevascularized territories, significant recovery was seen in only 1
(P<.001) and occurred at late follow-up. Individual changes
in wall motion in the revascularized regions from baseline to late
follow-up after PTCA are shown in Fig 3. The number of
normal segments increased from 70 to 104 segments. Twenty-four of 49
hypokinetic and 8 of 46 akinetic segments showed normal wall motion
after revascularization. Wall motion in an additional 6 segments
improved from akinetic to mildly hypokinetic. There were only 3
dyskinetic segments among those revascularized, none of which showed
recovery of function. A worsening of wall motion score by 1 grade was
seen in 7 segments. None of the segments worsened by >1 grade.
|
|
Patient-by-patient analysis (n=20) revealed that recovery of
function late after PTCA was seen in at least 1 segment in 12 patients
(60%) and in 2 contiguous segments in 10 patients (50%).
Results of Dobutamine Echocardiography
During DE, 15 of 20
(75%) patients received the maximal 40
µg/kg per minute dose of dobutamine. In 5 cases, the test was
terminated prematurely at a mean dose of 28±4.5 µg/kg per minute
(range, 20 to 30). The reasons for termination were: reaching >85%
predicted maximal heart rate in 3 patients, angina in 1, and
hypotension in another. Changes in heart rate and double product during
dobutamine infusion are shown in Fig 4. Compared with
resting values, significant changes in hemodynamics were not observed
until the dobutamine dose exceeded 10 µg/kg per minute.
|
During the dobutamine infusion, ventricular segments with abnormal resting function exhibited one of four responses: (1) biphasic response: improvement in wall motion at low doses with worsening at higher doses of dobutamine; (2) sustained improvement: improvement in wall motion at low doses that persisted or further improved until peak dose; (3) worsening: further deterioration of resting wall motion during DE without any improvement; and (4) no change: no change in wall motion during DE.
Of the 114 abnormal ventricular segments that were revascularized, 32 (28%) exhibited a biphasic response, 20 (18%) showed sustained improvement, 17 (15%) showed worsening, and 45 (39%) had no change in wall motion during dobutamine. Baseline characteristics and the magnitude of changes in wall motion during dobu- tamine for the segments exhibiting the above responses are detailed below.
Of the 32
segments that exhibited a biphasic response, 17 were
hypokinetic, 13 akinetic, and 2 mildly hypokinetic at baseline. During
low-dose dobutamine, the majority (62%) improved by 1 grade, while
38% of segments improved by 2 grades before reworsening at higher
dobutamine doses. The maximal initial improvement in wall motion was
seen at doses ranging from 2.5 to 30 µg/kg per minute but was most
prevalent (84%) at 7.5 µg/kg per minute (Fig 5).
Renewed worsening of wall motion during the biphasic response was seen
as early as the 7.5 µg/kg per minute dobutamine dose, but the
majority of segments (82%) worsened at 20 µg/kg per minute (Fig
5). There was no single low dose of dobu- tamine that allowed
detection of the improvement phase of all segments exhibiting a
biphasic response (Fig 5). The best combination of two low
doses for
this purpose was that of 5 and 7.5 µg/kg per minute, allowing
detection of wall motion improvement in 94% of biphasic segments.
Combining doses of 5, 7.5, and 10 µg/kg per minute allowed detection
of the improvement phase in all individual segments.
|
A sustained
improvement response during DE was seen in 20 segments, of
which 12 were hypokinetic, 4 akinetic, and 4 mildly hypokinetic at
baseline. Improvement in wall motion during DE started at 
10 µg/kg
per minute in 16 segments (80%). Maximal improvement in wall motion
was 1 grade in 14 segments (70%) and 2 grades in 6 segments.
Compared with segments exhibiting a biphasic response,
echocardiographic and angiographic characteristics of segments with
sustained improvement were similar (incidence of collaterals,
prevalence of 2 adjacent segments with normal wall motion). Although
a tendency for lower severity of coronary stenosis supplying segments
with sustained improvement was seen (84% versus 91%), this did not
reach statistical significance.
A "worsening only" response
of wall motion during DE occurred in
17 segments. Baseline wall motion in these segments was mildly
hypokinetic in 5, hypokinetic in 6, and akinetic in 6 segments. During
DE, 11 segments worsened by 1 grade, while the rest showed worsening of
2 or more grades. Only 4 of the 17 segments (24%) worsened at low
doses (10 µg/kg per minute). Segments with worsening response
tended to be supplied by more severely stenosed coronary arteries (92%
versus 88%). This difference, however, did not reach statistical
significance.
There were 45 abnormal segments in PTCA regions that showed no change in wall motion during DE. Over half of these (57%) were either akinetic (n=23) or dyskinetic (n=3) at baseline, while 14 were hypokinetic and 5 were mildly hypokinetic. Only 7 of these 45 segments had 2 or more normal adjacent segments (P<.01 compared with segments with other responses). Collaterals were present in 11 of these segments (P=NS compared with other segments).
Patients were classified according to the type of response observed in
the majority (50%) of abnormal segments. A biphasic response during
DE was seen in 9 patients, sustained improvement in 5, worsening in 4,
and no change in wall motion in 2 patients. The combination of 5 and
7.5 µg/kg per minute doses allowed detection of all patients with a
biphasic response. A history of angina was present in 5 of the 9
patients with a biphasic response, 2 of 5 with sustained improvement, 2
of 4 with worsening, and in the 2 patients with no change in wall
motion during DE. Patients who were given ß-blockers and those who
were not appeared to have similar types of response to DE. Of 8
patients on ß-blockers, 4 showed a biphasic response, 2 sustained
improvement, 1 worsening, and 1 no change in wall motion during DE.
Wall Motion Response During Dobutamine and Recovery of Ventricular
Function
The prediction of recovery of function of individual segments
at
late follow-up, analyzed by the type of wall motion response during
dobutamine, is shown in Fig 6. A biphasic response best
predicted recovery of resting function after revascularization. Of 32
segments with a biphasic response, 23 (72%) had recovery of
contractile function at late follow-up. On the other hand, of segments
exhibiting sustained improvement or no change, only 15% and 13%
showed functional recovery, respectively. Interestingly, 35% of
segments with a worsening response during dobutamine had recovery of
resting function.
|
Although a biphasic response was highly predictive of
recovery
of function after angioplasty, it was seen in only 23 of 38 segments
that recovered function, thus giving it a sensitivity of 60% (Fig
7). Combining both biphasic and worsening responses
resulted in a sensitivity and specificity of 74% and 73%,
respectively, with a positive predictive value of 59% and negative
predictive value of 86%.
|
When analyzed patient by patient, 8 of 9
patients with a biphasic
response (89%) showed recovery of function in 2 contiguous segments.
Recovery of function was seen in 1 of 4 patients with a worsening
response, 1 of 2 patients with no change in wall motion during DE, and
in none of the 5 with a sustained improvement response. The sensitivity
of a biphasic response was 80% (8 of 10), with a specificity of 90%.
Combining biphasic and worsening responses improved the sensitivity to
90%, with specificity of 60% (Fig 7
). History of exertional
angina
alone was only a fair predictor for recovery of ventricular function,
with 4 of 11 patients (36%) having recovery of function after
revascularization.
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
In the present study, significant improvement in ventricular function was observed in patients with stable coronary artery disease after revascularization with coronary angioplasty, the majority of which occurred early after revascularization. The prediction of recovery of function with dobutamine echocardiography depended on the type of wall motion response observed during dobutamine, the best being for a biphasic response and the worst for sustained improvement. Low doses as well as high doses of dobutamine are therefore needed for the optimal assessment of myocardial hibernation.
Myocardial Hibernation
Most of myocardial energy is spent for
maintenance of normal
contractile function. In the absence of coronary artery disease,
myocardial perfusion is closely matched to myocardial energy
requirements. When coronary flow is acutely reduced, myocardial energy
demands exceed supply, resulting in ischemia and contractile
dysfunction.11 If this imbalance in energy supply and
demand is not corrected, myocardial necrosis may occur.12
It is postulated that in some patients with coronary artery disease,
the myocardium may respond to chronic hypoperfusion by downregulating
contractile function, thereby reducing cardiac energy
demands.13 Myocardial hibernation, a term originally
coined by Rahimtoola,4 6 describes such a state in
patients with chronic ischemic heart disease, whereby restoration of
coronary flow allows recovery of ventricular contractile function.
Although to date animal models for myocardial hibernation have been
limited to short-term studies, this entity has been well documented
clinically.3 14 15 16
Patients with myocardial hibernation
appear to be at increased risk for future cardiac events, hence the
importance of identification of such patients who may benefit from
revascularization.5
In this study, we evaluated a patient
population with stable coronary
artery disease in whom reversible ventricular dysfunction is likely to
represent hibernation. We considered recovery of segmental
function to be significant only if wall motion improved by 2 grades,
making such changes more likely to be clinically relevant. Recovery of
function was seen in 33% of abnormal segments that were
revascularized. The dependence of functional recovery on restoration of
coronary blood flow is indicated by the lack of change in wall motion
score of regions that were not revascularized. Wall motion improved in
1 segment in 60% of patients and in 2 segments in 50% of
patients. This may not reflect a true incidence of hibernation, since
consecutive patients were not enrolled and the study was limited to
patients already scheduled to undergo angioplasty. Most of the recovery
in the hibernating ventricular segments was seen at early follow-up
(70%). This would suggest that hibernating myocardium has an intact
contractile apparatus that is downregulated due to hypoperfusion and
recovers quickly after revascularization. Early recovery of function
after revascularization has been reported by others,17
although prolonged postischemic dysfunction in patients with myocardial
hibernation also has been described.14 18
Dobutamine Echocardiography and Myocardial Hibernation
Contractile reserve of the stunned myocardium to inotropic
stimulation has been well demonstrated in the experimental setting and
more recently in patients with acute myocardial infarction undergoing
thrombolysis.8 9 19 Evidence regarding
contractile reserve
of the hibernating myocardium is less clear. Few studies have used
inotropic stimulation, postextrasystolic potentiation, or nitroglycerin
administration to predict recovery of function after
revascularization.20 21 22 23 24
Although there are no animal
models of chronic hibernation, data on short-term hibernation indicate
that hibernating myocardium retains contractile reserve, which may be
elicited during dobutamine infusion. In a swine model of short-term
hibernation, myocardial creatine phosphate levels initially declined,
reflecting a loss of energy production.25 However, while
the coronary stenosis was still maintained with depressed myocardial
contractility, creatine phosphate levels increased back toward normal.
Dobutamine infusion resulted in an improvement in contractility but
redepletion of creatine phosphate stores. This suggests that although
hibernating myocardium retains contractile reserve, the reserve is
probably limited. Further inotropic stimulation leads to depletion of
energy stores, resulting in ischemia.
In the present study, we
evaluated the type of response of the
dysfunctional myocardium to low and high doses of dobutamine.
Significant differences among responses were observed in the prediction
of recovery of function after revascularization, the highest being for
a biphasic response. The observed initial improvement in wall motion
probably represents recruitment of contractile reserve during
low-dose dobutamine. As the dobutamine dose is increased, ischemia
ensues, resulting in renewed worsening of wall motion. This is the
first description of a biphasic response specific for identifying
reversible dysfunction in patients with stable coronary artery disease.
A similar observation was recently made by Smart et al19
in patients early after acute myocardial infarction receiving
thrombolysis, a setting associated with myocardial stunning. The
observed magnitude of improvement in wall motion at low dose was
generally small (1 grade in 62% of segments); however, it was 2
grades in 38% of segments. Although a biphasic response was highly
predictive of recovery of function, it occurred in only 60% of
hibernating segments. Eighteen percent of hibernating segments showed
only worsening of wall motion during dobutamine, compatible with
ischemia. This probably indicates that some hibernating tissue is
supplied by such critically stenosed arteries that no contractile
reserve is present, and any increase in demand results in ischemia.
Segments with worsening response tended to be supplied by more severely
stenosed arteries, although the difference did not reach statistical
significance. Studies in larger populations might further clarify this
issue. Combining biphasic and worsening responses increased the
sensitivity of DE to 74%. On the other hand, a sustained improvement
in wall motion to dobutamine had a very low predictive value for
recovery of function. The underlying reason for this type of response
is unclear. Most segments with a sustained improvement response were
hypokinetic at baseline. However, these segments did not differ from
those exhibiting a biphasic response with respect to degree of coronary
stenosis, presence of collaterals, or number of normal adjacent
segments. Although the small number of observations may not allow for a
conclusive explanation, these segments did not exhibit worsening wall
motion and thus were probably not ischemic even at maximal stress.
Chronic resting ischemia is therefore not the underlying mechanism for
resting ventricular dysfunction, and revascularization in this
situation would not be expected to improve the resting dysfunction.
Conceivably, these segments may represent areas of
subendocardial infarction with a residual stenosis that is not flow
limiting and/or tethered myocardium. Further studies in a larger
population are needed to further understand the underlying basis of
this response.
Comparison With Previous Studies
Two recent studies using DE
to assess myocardial hibernation have
shown contractile reserve to be a marker of functional recovery after
coronary artery bypass.23 24 Both studies used only
low-dose dobutamine. Cigarroa et al24 reported an 82%
predictive value of DE for recovery of function. Data on patients were
reported, and analysis by segments was not performed. A sensitivity
of 86% was reported by LaCanna et al23 using segmental
analysis. The latter study may have been biased toward a positive
result, since patients enrolled were those who had indication of
viability by rest-redistribution thallium-201 scintigraphy, and this is
reflected in the high proportion (60%) of segments showing recovery of
function. There have been no previous studies evaluating the dose
response of the hibernating myocardium to dobutamine. In the
present study, the use of higher doses of dobutamine subgrouped
segments with initial improvement into those exhibiting a biphasic
response or a sustained improvement, responses that had contrasting
predictive values for functional recovery after revascularization.
Furthermore, the use of high-dose dobutamine identified a subset of
hibernating segments that exhibited only an ischemic response, without
contractile reserve. The importance of the use of high-dose dobutamine
is illustrated by the fact that, if the analysis in this study was
restricted to doses up to 10 µg/kg per minute, the sensitivity would
have decreased to 68% for segmental analysis and 80% for patients
with a further drop in specificity to 65% for segments and 40% for
patients. Since a high-dose DE was not performed in the previous
studies, it is not known whether a biphasic response would have been
observed, accounting for the reported predictive value of low-dose
dobutamine alone. Interestingly, even though doses of only 5 and
10 µg/kg per minute were used in one of the studies, some segments
did show improvement in wall motion at 5 µg/kg per minute and
deterioration at 10 µg/kg per minute.23
Although DE is useful in the assessment of myocardial hibernation, it can also underestimate viability in some cases. Thirteen percent of segments showing no change in wall motion in response to dobutamine had recovery of function after angioplasty. The majority of these segments were akinetic at rest, showing no change in wall motion during dobutamine. Whether the combination of dobutamine with nitroglycerin or ATP administration may improve detection of myocardial hibernation in these cases remains to be determined.
Study Advantages and Limitations
Angioplasty was chosen as
the revascularization procedure for
several reasons. After coronary artery bypass, wall motion may be
influenced by postoperative stunning or hyperdynamicity resulting from
use of inotropes, anemia, or infection. In addition, infarction after
bypass may be difficult to diagnose and can confound assessment of
changes in wall motion. Furthermore, since septal motion becomes
paradoxical after bypass surgery, it would be difficult to blind the
reader to timing of the echocardiographic studies. PTCA is a
well-established technique for myocardial revascularization with a high
success rate. A limitation of using angioplasty as the
revascularization modality is restenosis. We excluded patients
undergoing PTCA of a bypass graft due to the higher rate of restenosis.
All patients, except 2 who underwent bypass, had satisfactory
angiographic results. No patient had recurrent angina or complications
after the procedure. In this study, patients enrolled were
nonconsecutive and already scheduled to undergo PTCA, the majority
based on either clinical grounds or a positive stress test suggesting
the presence of ischemia. However, DE was not used in the decision
process. Further studies in larger populations are needed to assess the
predictive value of DE in suspected myocardial hibernation.
Serial resting echocardiographic images were digitized in comparable views and randomized for interpretation. Although this format puts the echocardiographer at a disadvantage by not providing intermediate echocardiographic views and a large number of cardiac cycles for evaluation of regional function, it helps reduce bias in interpretation and ensures comparability of tomographic images. Although wall motion was not quantitated, the advantage of qualitative assessment of regional function, along with the derivation of a semiquantitative wall motion score, is the enhanced ability to assess wall motion by integrating information from multiple views. This lessens the problems of endocardial dropout and lateral resolution that may occur depending on the imaging window.
We excluded patients with unstable ischemic syndromes and studied only patients with stable significant coronary artery disease in whom reversible ventricular dysfunction is more likely to represent hibernation. The possibility of silent ischemia resulting in stunning cannot be excluded in the absence of perfusion data. However, the presence of wall motion abnormality on two separate studies before revascularization and the observation that recovery of function in serial studies was seen almost exclusively in revascularized segments strongly support hibernation rather than stunning as the underlying entity in our study group.
Clinical Implications: Optimal Dobutamine Dose and Quad-Screen
Display
The finding that DE can predict recovery of function after
revascularization has considerable implications for patient management
and risk assessment. Our results suggest the need for both low and high
doses of dobutamine for optimal assessment of myocardial viability
in patients with stable coronary artery disease. Although no single low
dose allowed detection of all segments exhibiting the improvement phase
of the biphasic response, the best combination of two low doses to be
displayed was that of 5 and 7.5 µg/kg per minute. Since current
digital echocardiographic technology allows viewing a maximum of four
simultaneous images (quad screen), a display of resting images as well
as those of 5 and 7.5 µg/kg per minute and peak dobutamine doses on a
quad screen would allow optimal assessment of myocardial
hibernation.
|
Acknowledgments |
|---|
Computational assistance was provided by the CLINFO Project, funded by grant PR-00350 from the Division of Research Resources, National Institutes of Health, Bethesda, Md. The authors thank Eula Landry for her assistance in the preparation of the manuscript.
|
Footnotes |
|---|
The guest editor was Robert A. O'Rourke, MD, University of Texas Health Science Center, San Antonio, Tex.
Received May 11, 1994; accepted September 23, 1994.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Cabin HS, Clubb KS, Vita N, Zaret BL. Regional dysfunction by equilibrium radionuclide angiocardiography: a clinicopathologic study evaluating the relation of degree of dysfunction to the presence and extent of myocardial infarction. J Am Coll Cardiol. 1987;10:743-747. [Abstract]
2. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66: 1146-1149.
3. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the `hibernating myocardium.' J Am Coll Cardiol. 1986;8:1467-1470. [Medline] [Order article via Infotrieve]
4. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221. [Medline] [Order article via Infotrieve]
5. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20:559-565. [Abstract]
6. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(suppl V):V-123-V-135.
7. Lemlek J, Heo J, Iskandrian AS. The clinical relevance of myocardial viability in patient management. Am Heart J. 1992;124: 1327-1331.
8. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15:1021-1031. [Abstract]
9. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J. 1991;122: 1522-1531.
10. Van Reet RE, Quiñones MA, Poliner LA, Nelson J, Waggoner A, Hanon D, Lubetkin S, Pratt CM, Winters WL Jr. Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in the evaluation of global and regional left ventricular function in acute myocardial infarction. J Am Coll Cardiol. 1984;3:243-252. [Abstract]
11. Tennant R, Wiggers CJ. The effect of coronary occlusion on myocardial contraction. Am J Physiol. 1935;112:351-361.
12. Blumgart HL, Gilligan DR, Schlesinger MJ. Experimental studies on the effect of temporary occlusion of the coronary arteries: the production of myocardial infarction. Am Heart J. 1941;22:374-389.
13. Ross J Jr. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation. 1991;83: 1076-1083.
14. Baker WB, Klein MS, Reardon MJ, Verani MS, Zoghbi WA. Reversible cardiac dysfunction (hibernation) from ischemia due to compression of the coronary arteries by a pseudoaneurysm. N Engl J Med. 1991;325:1858-1861. [Medline] [Order article via Infotrieve]
15.
Montalescot G, Faraggi M, Drobinski G, Messian O, Evans J,
Grosgogeat Y, Thomas D. Myocardial viability in patients with Q-wave
myocardial infarction and no residual ischemia.
Circulation. 1992;86:47-55.
16. Lewis SJ, Sawada SG, Ryan T, Segar DS, Armstrong WF, Feigenbaum H. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J. 1991;121:1088-1094. [Medline] [Order article via Infotrieve]
17. Topol EJ, Weiss JL, Guzman PA, Dorsey-Lima S, Blancc TJJ, Humphrey LS, Baumgartner WA, Flaherty JT, Reitz BA. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol. 1984;4:1123-1134. [Abstract]
18. Mintz LY, Ingels HB, Daughters GI, Stinson EB, Alderman EL. Sequential studies of left ventricular function and wall motion after coronary bypass surgery. Am J Cardiol. 1980;45:210-216. [Medline] [Order article via Infotrieve]
19.
Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K,
Bourdillon PD, Feigenbaum H. Low-dose dobutamine echocardiography
detects reversible dysfunction after thrombolytic therapy of acute
myocardial infarction. Circulation. 1993;88:405-415.
20. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy: correlation with post coronary bypass ventriculography. Circulation. 1974;50: 108-113.
21. Nesto RW, Cohn LH, Wynne J, Holman L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol. 1982;50:39-44. [Medline] [Order article via Infotrieve]
22. Popio KA, Gorlin R, Bechtel D, Levine JA. Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol. 1977;39:944-953. [Medline] [Order article via Infotrieve]
23. La Canna G, Alfiere O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617-626. [Abstract]
24. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88: 430-436.
25.
Schulz R, Guth BD, Pieper K, Martin C, Heusch G. Recruitment
of an inotropic reserve in moderately ischemic myocardium at the
expense of metabolic recovery: a model of short-term hibernation.
Circ Res. 1992;70:1282-1295.
This article has been cited by other articles:
 |
|
 |
|
  V Rizzello, D Poldermans, E Biagini, A F L Schinkel, E Boersma, A Boccanelli, T Marwick, J R T C Roelandt, and J J Bax Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction Heart, August 1, 2009; 95(15): 1273 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hoeks and D. Poldermans CHAPTER 34 Non-cardiac Surgery in Cardiac Patients ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rahimtoola, V. Dilsizian, C. M. Kramer, T. H. Marwick, and J.-L. J. Vanoverschelde Chronic ischemic left ventricular dysfunction from pathophysiology to imaging and its integration into clinical practice. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 536 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cianfrocca, F. Pelliccia, A. Auriti, V. Guido, V. Pasceri, X. Li, G. Richichi, G. Mercuro, and M. Santini Levosimendan allows detection of contractile reserve in patients with chronic ischaemic left ventricular dysfunction and non-diagnostic dobutamine echocardiography Eur J Heart Fail, September 1, 2007; 9(9): 897 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Banas, S. Baldwa, G. Suzuki, J. M. Canty Jr., and J. A. Fallavollita Determinants of contractile reserve in viable, chronically dysfunctional myocardium Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2791 - H2797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Karagiannis, H. H.H. Feringa, J. J. Bax, A. Elhendy, M. Dunkelgrun, R. Vidakovic, S.E. Hoeks, R. van Domburg, R. Valhema, D. V. Cokkinos, et al. Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration Eur J Heart Fail, April 1, 2007; 9(4): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Bove, J. M. DiMaria, S. Voros, M. R. Conaway, and C. M. Kramer Dobutamine Response and Myocardial Infarct Transmurality: Functional Improvement after Coronary Artery Bypass Grafting--Initial Experience Radiology, September 1, 2006; 240(3): 835 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Rizzello, D. Poldermans, E. Biagini, A. F.L. Schinkel, E. Boersma, A. Elhendy, F. B. Sozzi, A. Maat, J. R.T.C. Roelandt, and J. J. Bax Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: Role of myocardial viability Eur J Heart Fail, May 1, 2006; 8(3): 314 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hasegawa, H. Takano, K. Iwanaga, M. Ohtsuka, Y. Qin, Y. Niitsuma, K. Ueda, T. Toyoda, H. Tadokoro, and I. Komuro Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia J. Am. Coll. Cardiol., February 21, 2006; 47(4): 842 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Rizzello, D Poldermans, A F L Schinkel, E Biagini, E Boersma, A Elhendy, F B Sozzi, A Maat, F Crea, J R T C Roelandt, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation Heart, February 1, 2006; 92(2): 239 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gorcsan III Echocardiographic Strain Imaging for Myocardial Viability: An Improvement Over Visual Assessment? Circulation, December 20, 2005; 112(25): 3820 - 3822. [Full Text] [PDF]
|
|
|
|
|
|
L. Hanekom, C. Jenkins, L. Jeffries, C. Case, J. Mundy, C. Hawley, and T. H. Marwick Incremental Value of Strain Rate Analysis as an Adjunct to Wall-Motion Scoring for Assessment of Myocardial Viability by Dobutamine Echocardiography: A Follow-Up Study After Revascularization Circulation, December 20, 2005; 112(25): 3892 - 3900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Armstrong and W. A. Zoghbi Stress Echocardiography: Current Methodology and Clinical Applications J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1739 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yoshinaga, C. Katoh, R. S.B. Beanlands, K. Noriyasu, K. Komuro, S. Yamada, Y. Kuge, K. Morita, A. Kitabatake, and N. Tamaki Reduced Oxidative Metabolic Response in Dysfunctional Myocardium with Preserved Glucose Metabolism but with Impaired Contractile Reserve J. Nucl. Med., November 1, 2004; 45(11): 1885 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Rizzello, D. Poldermans, E. Boersma, E. Biagini, A. F.L. Schinkel, B. Krenning, A. Elhendy, E. C. Vourvouri, F. B. Sozzi, A. Maat, et al. Opposite Patterns of Left Ventricular Remodeling After Coronary Revascularization in Patients With Ischemic Cardiomyopathy: Role of Myocardial Viability Circulation, October 19, 2004; 110(16): 2383 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zaugg, M. C. Schaub, and P. Foex Myocardial injury and its prevention in the perioperative setting Br. J. Anaesth., July 1, 2004; 93(1): 21 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Go, M. R. Bhatt, and R. C. Hendel The Diagnostic and Prognostic Value of ECG-Gated SPECT Myocardial Perfusion Imaging J. Nucl. Med., May 1, 2004; 45(5): 912 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J H McGowan Hibernating myocardium: high or low risk? Heart, March 1, 2004; 90(3): 237 - 238. [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Biswas, G. C. Hughes, J. E. Scarborough, P. W. Domkowski, L. Diodato, M. L. Smith, C. Landolfo, J. E. Lowe, B. H. Annex, and K. P. Landolfo Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: A comparative study J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 34 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography) J. Am. Coll. Cardiol., September 3, 2003; 42(5): 954 - 970. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) Circulation, September 2, 2003; 108(9): 1146 - 1162. [Full Text] [PDF]
|
|
|
|
|
|
R. Southworth and P. B. Garlick Dobutamine responsiveness, PET mismatch, and lack of necrosis in low-flow ischemia: is this hibernation in the isolated rat heart? Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H316 - H324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lancellotti, E. P. Hoffer, and L. A. Pierard Detection and clinical usefulness of a biphasic response during exercise echocardiography early after myocardial infarction J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1142 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shimoni, N. G. Frangogiannis, C. J. Aggeli, K. Shan, M. S. Verani, M. A. Quinones, R. Espada, G. V. Letsou, G. M. Lawrie, W. L. Winters, et al. Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography: Comparison With Dobutamine Echocardiography and Thallium-201 Scintigraphy Circulation, February 4, 2003; 107(4): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meluzin, J. Cerny, L. Spinarova, J. Toman, L. Groch, F. Stetka, M. Frelich, P. Hude, J. Krejci, L. Rambouskova, et al. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability Eur J Heart Fail, January 1, 2003; 5(1): 85 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Yetkin, K. Senen, M. Ileri, R. Atak, B. Battaoglu, O. Yetkin, I. Tandogan, H. Turhan, and S. Cehreli Identification of Viable Myocardium in Patients with Chronic Coronary Artery Disease and Myocardial Dysfunction: Comparison of Low-Dose Dobutamine Stress Echocardiography and Echocardiography During Glucose-Insulin-Potassium Infusion Angiology, November 1, 2002; 53(6): 671 - 676. [Abstract] [PDF]
|
|
|
|
 |
|
 F. W. Dupont, R. M. Lang, M. L. Drum, and S. Aronson Is There a Long-Term Predictive Value of Intraoperative Low-Dose Dobutamine Echocardiography in Patients Who Have Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass? Anesth. Analg., September 1, 2002; 95(3): 517 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shimoni, N. G. Frangogiannis, C. J. Aggeli, K. Shan, M. A. Quinones, R. Espada, G. V. Letsou, G. M. Lawrie, W. L. Winters, M. J. Reardon, et al. Microvascular Structural Correlates of Myocardial Contrast Echocardiography in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Implications for the Assessment of Myocardial Hibernation Circulation, August 20, 2002; 106(8): 950 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F.M van den Heuvel, J. J Bax, P. K Blanksma, W. Vaalburg, H. J.G.M Crijns, and D. J van Veldhuisen Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients Cardiovasc Res, July 1, 2002; 55(1): 97 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bax, J. Maddahi, D. Poldermans, A. Elhendy, J. H. Cornel, E. Boersma, J. R.T.C. Roelandt, and P. M. Fioretti Sequential 201Tl Imaging and Dobutamine Echocardiography to Enhance Accuracy of Predicting Improved Left Ventricular Ejection Fraction After Revascularization J. Nucl. Med., June 1, 2002; 43(6): 795 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Chin, G. Esposito, and D. L. Kraitchman Myocardial Contractile Reserve and Perfusion Defect Severity with Rest and Stress Dobutamine 99mTc-Sestamibi SPECT in Canine Stunning and Subendocardial Infarction J. Nucl. Med., April 1, 2002; 43(4): 540 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Zaglavara, R Haaverstad, B Cumberledge, T Irvine, H Karvounis, G Parharidis, G Louridas, and A Kenny Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking {beta} blockers: accuracy and optimal dose Heart, April 1, 2002; 87(4): 329 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Frangogiannis, S. Shimoni, S. M. Chang, G. Ren, K. Shan, C. Aggeli, M. J. Reardon, G. V. Letsou, R. Espada, M. Ramchandani, et al. Evidence for an Active Inflammatory Process in the Hibernating Human Myocardium Am. J. Pathol., April 1, 2002; 160(4): 1425 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Piscione, P Perrone-Filardi, G De Luca, M Prastaro, C Indolfi, P Golino, S Dellegrottaglie, and M Chiariello Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation Heart, December 1, 2001; 86(6): 679 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. del Mar de la Torre, J. A. San Roman, J. Bermejo, G. Pastor, J. Alonso, and F. Fernandez-Aviles Prognostic Power of Dobutamine Echocardiography After Uncomplicated Acute Myocardial Infarction in the Elderly Chest, October 1, 2001; 120(4): 1200 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Hughes, C. K. Landolfo, B. Yin, T. R. DeGrado, R. E. Coleman, K. P. Landolfo, and J. E. Lowe Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? Ann. Thorac. Surg., July 1, 2001; 72(1): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Iglesias-Garriz, F.e. Corral, M. A. Rodriguez, C. Garrote, M. Montes, and E. Sevillano Pre-infarction angina elicits greater myocardial viability on reperfusion after myocardial infarction: a dobutamine stress echocardiographic study J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1846 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshinaga, K. Morita, S. Yamada, K. Komuro, C. Katoh, Y. Ito, Y. Kuge, T. Kohya, A. Kitabatake, and N. Tamaki Low-Dose Dobutamine Electrocardiograph-Gated Myocardial SPECT for Identifying Viable Myocardium: Comparison with Dobutamine Stress Echocardiography and PET J. Nucl. Med., June 1, 2001; 42(6): 838 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Sicari, A Ripoli, E Picano, A.C Borges, A Varga, W Mathias, L Cortigiani, R Bigi, J Heyman, S Polimeno, et al. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction Eur. Heart J., May 2, 2001; 22(10): 837 - 844. [Abstract] [PDF]
|
|
|
|
|
|
P Lancellotti, A Albert, C Berthe, and L A Piérard Full recovery of contraction late after acute myocardial infarction: determinants and early predictors Heart, May 1, 2001; 85(5): 521 - 526. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Yong, S. F. Nagueh, S. Shimoni, K. Shan, Z.-X. He, M. J. Reardon, G. V. Letsou, J. F. Howell, M. S. Verani, M. A. Quinones, et al. Deceleration Time in Ischemic Cardiomyopathy : Relation to Echocardiographic and Scintigraphic Indices of Myocardial Viability and Functional Recovery After Revascularization Circulation, March 6, 2001; 103(9): 1232 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium J. Am. Coll. Cardiol., January 1, 2001; 37(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wolf, L. Gepstein, G. Hayam, A. Zaretzky, R. Shofty, D. Kirshenbaum, G. Uretzky, U. Oron, and S. A. Ben-Haim Three-dimensional endocardial impedance mapping: a new approach for myocardial infarction assessment Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H179 - H188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Bin, R. A. Pelberg, K. Wei, M. Coggins, N. C. Goodman, and S. Kaul Relation between regional function and coronary blood flow reserve in multivessel coronary artery stenosis Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3058 - H3064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shan, R. J. Bick, B. J. Poindexter, S. F. Nagueh, S. Shimoni, M. S. Verani, F. Keng, M. J. Reardon, G. V. Letsou, J. F. Howell, et al. Altered Adrenergic Receptor Density in Myocardial Hibernation in Humans : A Possible Mechanism of Depressed Myocardial Function Circulation, November 21, 2000; 102(21): 2599 - 2606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G LaCanna, S.H Rahimtoola, O Visioli, R Giubbini, O Alfieri, M Zognio, E Milan, C Ceconi, M Gargano, R LoRusso, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium Eur. Heart J., August 2, 2000; 21(16): 1358 - 1367. [Abstract] [PDF]
|
|
|
|
|
|
F.M Baer, P Theissen, J Crnac, M Schmidt, H.J Deutsch, U Sechtem, H Schicha, and E Erdmann Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease Eur. Heart J., June 2, 2000; 21(12): 981 - 991. [Abstract] [PDF]
|
|
|
|
|
|
K. Takehana, M. Ruiz, F. D. Petruzella, D. D. Watson, G. A. Beller, and D. K. Glover Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1960 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. St. Louis, G. C. Hughes, A. P. Kypson, T. R. DeGrado, C. L. Donovan, R. E. Coleman, B. Yin, C. Steenbergen, K. P. Landolfo, and J. E. Lowe An experimental model of chronic myocardial hibernation Ann. Thorac. Surg., May 1, 2000; 69(5): 1351 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Cwajg, E. Cwajg, S. F. Nagueh, Z.-X. He, U. Qureshi, L. I. Olmos, M. A. Quinones, M. S. Verani, W. L. Winters, and W. A. Zoghbi End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: Relation to rest-redistribution Tl-201 tomography and dobutamine stress echocardiography J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1152 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lu, M. Carlino, G. Fragasso, F. Maisano, A. Margonato, A. Cappelletti, and S. L. Chierchia Enoximone Echocardiography for Predicting Recovery of Left Ventricular Dysfunction After Revascularization : A Novel Test for Detecting Myocardial Viability Circulation, March 21, 2000; 101(11): 1255 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pasquet, M.S. Lauer, M.J. Williams, M.-A. Secknus, B. Lytle, and T.H. Marwick Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism Eur. Heart J., January 2, 2000; 21(2): 125 - 136. [Abstract] [PDF]
|
|
|
|
|
|
F. Barilla Reply J. Am. Coll. Cardiol., January 1, 2000; 35(1): 258 - 259. [Full Text] [PDF]
|
|
|
|
|
|
R J Trent, G D Waiter, G S Hillis, F I McKiddie, T W Redpath, and S Walton Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation Heart, January 1, 2000; 83(1): 40 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Hoffer, W. Dewe, C. Celentano, and L. A. Pierard Low-level exercise echocardiography detects contractile reserve and predicts reversible dysfunction after acute myocardial infarction: Comparison with low-dose dobutamine echocardiography J. Am. Coll. Cardiol., October 1, 1999; 34(4): 989 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Monin, J.e. Garot, M. Scherrer-Crosbie, J. Rosso, A.-M. Duval-Moulin, P. Dupouy, E. Teiger, A. Castaigne, J.-C. Cachin, J.-L. Dubois-Rande, et al. Prediction of functional recovery of viable myocardium after delayed revascularization in postinfarction patients: Accuracy of dobutamine stress echocardiography and influence of long-term vessel patency J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1012 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Larrazet, D Pellerin, D Daou, S Witchitz, C Fournier, A Prigent, and C Veyrat Concordance between dobutamine Doppler tissue imaging echocardiography and rest reinjection thallium-201 tomography in dysfunctional hypoperfused myocardium Heart, October 1, 1999; 82(4): 432 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Chaudhry, J. T. Tauke, R. S. Alessandrini, G. Vardi, M. A. Parker, and R. O. Bonow Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., September 1, 1999; 34(3): 730 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Nagueh, I. Mikati, D. Weilbaecher, M. J. Reardon, G. J. Al-Zaghrini, D. Cacela, Z.-X. He, G. Letsou, G. Noon, J. F. Howell, et al. Relation of the Contractile Reserve of Hibernating Myocardium to Myocardial Structure in Humans Circulation, August 3, 1999; 100(5): 490 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Fath-Ordoubadi, K J Beatt, N Spyrou, and P G Camici Efficacy of coronary angioplasty for the treatment of hibernating myocardium Heart, August 1, 1999; 82(2): 210 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bax, D. Poldermans, A. Elhendy, J. H. Cornel, E. Boersma, R. Rambaldi, J. R. T. C. Roelandt, and P. M. Fioretti Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography J. Am. Coll. Cardiol., July 1, 1999; 34(1): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Auerbach, H. Schoder, C. Hoh, S. S. Gambhir, S. Yaghoubi, J. W. Sayre, D. Silverman, M. E. Phelps, H. R. Schelbert, and J. Czernin Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients With Ischemic Cardiomyopathy Circulation, June 8, 1999; 99(22): 2921 - 2926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Barilla, G. De Vincentis, E. Mangieri, M. Ciavolella, G. Pannitteri, F. Scopinaro, G. Critelli, and P. P. Campa Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling J. Am. Coll. Cardiol., March 1, 1999; 33(3): 697 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smart, P. N. Dionisopoulos, T. A. Knickelbine, T. Schuchard, and K. B. Sagar Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction J. Am. Coll. Cardiol., February 1, 1999; 33(2): 512 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Acquatella, J. E. Perez, J. A. Condado, and I. Sanchez Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas' disease: Assessment by dobutamine stress echocardiography J. Am. Coll. Cardiol., February 1, 1999; 33(2): 522 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Baumgartner, G. Porenta, Y.-K. Lau, M. Wutte, U. Klaar, M. Mehrabi, R. J. Siegel, J. Czernin, G.u. Laufer, H. Sochor, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: Correlation with histopathology in explanted hearts J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1701 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Gunning, C. Anagnostopoulos, C. J. Knight, J. Pepper, E. D. Burman, G. Davies, K. M. Fox, D. J. Pennell, P. J. Ell, and S. R. Underwood Comparison of 201Tl, 99mTc-Tetrofosmin, and Dobutamine Magnetic Resonance Imaging for Identifying Hibernating Myocardium Circulation, November 3, 1998; 98(18): 1869 - 1874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meluzin, J. Cerny, M. Frelich, F. Stetka, L. Spinarova, J. Popelova, R. Stipal, and on behalf of the Investigators of This Multicenter Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 912 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Afridi, P. A. Grayburn, J. A. Panza, J. K. Oh, W. A. Zoghbi, and T. H. Marwick Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 921 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Steendijk, J. Baan Jr., E. T. Van Der Velde, and J. Baan Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart J. Am. Coll. Cardiol., September 1, 1998; 32(3): 816 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S R Redwood, R Ferrari, and M S Marber Myocardial hibernation and stunning: from physiological principles to clinical practice Heart, September 1, 1998; 80(3): 218 - 222. [Full Text]
|
|
|
|
 |
|
 W. Wijns, S. F. Vatner, and P. G. Camici Hibernating Myocardium N. Engl. J. Med., July 16, 1998; 339(3): 173 - 181. [Full Text] [PDF]
|
|
|
|
|
|
D Pagano, R S Bonser, J N Townend, F Ordoubadi, R Lorenzoni, and P G Camici Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure Heart, March 1, 1998; 79(3): 281 - 288. [Abstract] [Full Text]
|
|
|
|
|
|
L. Ma, L. Chen, L. Gillam, D. D Waters, and C. Chen Nitroglycerin Enhances the Ability of Dobutamine Stress Echocardiography to Detect Hibernating Myocardium Circulation, December 2, 1997; 96(11): 3992 - 4001. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Genma, S. Ogawa, J. Zhang, and M. Yamamoto Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signal-averaged ventricular late potentials Cardiovasc Res, December 1, 1997; 36(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ogawa, R. Fukazawa, T. Ohkubo, J. Zhang, N. Takechi, Y. Kuramochi, Y. Hino, O. Jimbo, Y. Katsube, M. Kamisago, et al. Silent Myocardial Ischemia in Kawasaki Disease : Evaluation of Percutaneous Transluminal Coronary Angioplasty by Dobutamine Stress Testing Circulation, November 18, 1997; 96(10): 3384 - 3389. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Meza, S. Ramee, T. Collins, D. Stapleton, R. V. Milani, J. P. Murgo, and J. Cheirif Knowledge of Perfusion and Contractile Reserve Improves the Predictive Value of Recovery of Regional Myocardial Function Postrevascularization : A Study Using the Combination of Myocardial Contrast Echocardiography and Dobutamine Echocardiography Circulation, November 18, 1997; 96(10): 3459 - 3465. [Abstract] [Full Text]
|
|
|
|
|
|
H. H. Lee, V. G. Davila-Roman, P. A. Ludbrook, M. Courtois, J. F. Walsh, D. A. Delano, P. J. Rubin, and R. J. Gropler Dependency of Contractile Reserve on Myocardial Blood Flow : Implications for the Assessment of Myocardial Viability With Dobutamine Stress Echocardiography Circulation, November 4, 1997; 96(9): 2884 - 2891. [Abstract] [Full Text]
|
|
|
|
|
|
A. Elsasser, M. Schlepper, W.-P. Klovekorn, W.-j. Cai, R. Zimmermann, K.-D. Muller, R. Strasser, S. Kostin, C. Gagel, B. Munkel, et al. Hibernating Myocardium : An Incomplete Adaptation to Ischemia Circulation, November 4, 1997; 96(9): 2920 - 2931. [Abstract] [Full Text]
|
|
|
|
|
|
A. Cohen, C. Chauvel, B. Benhalima, P. Guyon, I. Desert, J. Valty, and A. Cohen Is Dobutamine Stress Echocardiography Useful for Noninvasive Differentiation of Ischemic from Idiopathic Dilated Cardiomyopathy? Angiology, September 1, 1997; 48(9): 783 - 793. [Abstract] [PDF]
|
|
|
|
|
|
G. von Degenfeld, W. Giehrl, and P. Boekstegers Targeting of dobutamine to ischemic myocardium without systemic effects by selective suction and pressure-regulated retroinfusion Cardiovasc Res, August 1, 1997; 35(2): 233 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. J. Vanoverschelde, W. Wijns, M. Borgers, G. Heyndrickx, C. Depre, W. Flameng, and J. A. Melin Chronic Myocardial Hibernation in Humans: From Bedside to Bench Circulation, April 1, 1997; 95(7): 1961 - 1971. [Full Text]
|
|
|
|
|
|
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography Circulation, March 18, 1997; 95(6): 1686 - 1744. [Full Text]
|
|
|
|
|
|
U. Qureshi, S. F. Nagueh, I. Afridi, P. Vaduganathan, A. Blaustein, M. S. Verani, W. L. Winters, and W. A. Zoghbi Dobutamine Echocardiography and Quantitative Rest-Redistribution 201Tl Tomography in Myocardial Hibernation: Relation of Contractile Reserve to 201Tl Uptake and Comparative Prediction of Recovery of Function Circulation, February 4, 1997; 95(3): 626 - 635. [Abstract] [Full Text]
|
|
|
|
|
|
S. H. Rahimtoola Hibernating Myocardium Has Reduced Blood Flow at Rest That Increases With Low-Dose Dobutamine Circulation, December 15, 1996; 94(12): 3055 - 3061. [Full Text]
|
|
|
|
|
|
R. O. Bonow Identification of Viable Myocardium Circulation, December 1, 1996; 94(11): 2674 - 2680. [Full Text]
|
|
|
|
|
|
C. R. deFilippi, D. L. Willett, W. N. Irani, E. J. Eichhorn, C. E. Velasco, and P. A. Grayburn Comparison of Myocardial Contrast Echocardiography and Low-Dose Dobutamine Stress Echocardiography in Predicting Recovery of Left Ventricular Function After Coronary Revascularization in Chronic Ischemic Heart Disease Circulation, November 15, 1995; 92(10): 2863 - 2868. [Abstract] [Full Text]
|
|
|
|
 |
|
 Finding Hibernating Myocardium with Dobutamine Echo Journal Watch Cardiology, April 1, 1995; 1995(401): 11 - 11. [Full Text]
|
|
|
|
|
|
J. N. Oshinski, H.-C. Han, D. N. Ku, and R. I. Pettigrew Quantitative Prediction of Improvement in Cardiac Function after Revascularization with MR Imaging and Modeling: Initial Results Radiology, November 1, 2001; 221(2): 515 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Choi, R. J. Kim, G. Gubernikoff, J. D. Vargas, M. Parker, and R. M. Judd Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function Circulation, September 4, 2001; 104(10): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Kalra, X. Zhu, M. K. Ramchandani, G. Lawrie, M. J. Reardon, D. Lee-Jackson, W. L. Winters, N. Sivasubramanian, D. L. Mann, and W. A. Zoghbi Increased Myocardial Gene Expression of Tumor Necrosis Factor-{alpha} and Nitric Oxide Synthase-2: A Potential Mechanism for Depressed Myocardial Function in Hibernating Myocardium in Humans Circulation, April 2, 2002; 105(13): 1537 - 1540. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||